Dr. Henk-Jan van den Ham leads ENPICOM’s Research Team. Henk-Jan studied Biomedical Sciences (Infection & Immunity) and moved from the wet into the dry lab to do a Ph.D. in Theoretical Immunology & Bioinformatics, both at Utrecht University, the Netherlands. He performed postdoctoral work at the department of Virology/Viroscience in Rotterdam, the Netherlands, where he used omics technologies and bioinformatics to study virus-host interactions.
At ENPICOM, Henk-Jan focuses on the latest developments in immunology and bioinformatics, specifically those within adaptive immune repertoire analysis and immunogenomics. This includes participation in academic and industry collaborative projects, grant applications, and contract research at the interface of immunology, bioinformatics, and software engineering. Henk-Jan also contributes guest lectures to various master programs, supervises master students, and participates in repertoire-related committees and several research networks.
As Team Lead Product Management at ENPICOM, Dr. Lorenzo Fanchi is responsible for the ongoing development of the IGX Platform, both by improving current apps and functionality, as well as by developing completely novel solutions to address new markets. He manages all phases of product development: from product discovery, envisioning and prototyping solutions to guiding development and implementation. Before products are launched to market, he is involved in guiding sales training and marketing/promotional activities.
Previously, during his Ph.D. at the Schumacher lab at the Netherlands Cancer Institute, Lorenzo worked on a variety of projects ranging from in vitro and in vivo work, where he explored approaches to improve adoptive cell therapy of cancer, to in silico projects which assessed the immunological foreignness of human cancers. Finally, he was involved in several clinical trials where he explored the use of repertoire sequencing data to identify therapy-induced changes in patients treated with immunotherapeutic intervention strategies.